- Home » News and EventsPage 35
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
FDA Approve Symbiomix’s Solosec™; Follows Four-Year Collaboration with Catalent
Oct 2, 2017
Catalent Pharma Solutions today welcomed Symbiomix Therapeutics’ announcement that the U.S. Food and Drug Administration (FDA) has approved Solosec™ (secnidazole) 2g oral granules for the treatment of…
Catalent to Host Workshops on Bioassay Development at Upcoming Conferences
Sep 25, 2017
Catalent Pharma Solutions today announced that two of its leading biologics analytical experts will be presenting workshops on the development and validation of bioassays at two upcoming conferences. …
Catalent to Acquire Cook Pharmica for $950 Million
Sep 19, 2017
Catalent to Acquire Cook Pharmica for $950 Million. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health prod…
Catalent to Lead Informative Sessions at SupplySide West
Sep 18, 2017
SOMERSET, N.J. – September 18, 2017 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health produc…
Catalent Invests to Increase Clinical Storage Capacity at Philadelphia Site
Sep 14, 2017
Catalent Pharma Solutions today announced that it is investing $5.5 million at its 200,000+ square foot Philadelphia, Pennsylvania, site to provide additional clinical packaging and storage capacity.
Catalent Invests to Increase Clinical Storage Capacity at Philadelphia Site
Sep 14, 2017
Catalent Invests to Increase Clinical Storage Capacity at Philadelphia Site. SOMERSET, N.J. – September 14, 2017 — Catalent Pharma Solutions, the leading global provider of advanced delivery technolog…
Catalent Signs Commercial Manufacturing Agreement with US WorldMeds
Sep 5, 2017
Catalent Pharma Solutions today announced it has entered into an exclusive agreement with US WorldMeds, LLC for the commercial manufacture of lofexidine. SOMERSET, N.J. – September 5, 2017 — Catalent …
Catalent Applied Drug Delivery Institute Appoints Jim Spavins to Advisory Board
Jul 26, 2017
The Catalent Applied Drug Delivery Institute today announced that Mr. SOMERSET, N.J. – July 26, 2017 — The Catalent Applied Drug Delivery Institute today announced that Mr. Spavins brings over 36 year…
Catalent Applied Drug Delivery Institute Partners with Rutgers University
Jul 20, 2017
Catalent Applied Drug Delivery Institute Partners with Rutgers University. Somerset, N.J. – July 20, 2017 — The Catalent Applied Drug Delivery Institute today announced that it has entered into a coll…
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.